Analysts predict that Indaptus Therapeutics, Inc. (NASDAQ:INDP – Get Rating) will report earnings per share of ($0.43) for the current quarter, Zacks reports. Zero analysts have made estimates for Indaptus Therapeutics’ earnings. Indaptus Therapeutics posted earnings of ($5.53) per share in the same quarter last year, which would suggest a positive year over year growth […]
Q BioMed (OTCMKTS:QBIO – Get Rating) and Indaptus Therapeutics (NASDAQ:INDP – Get Rating) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, risk, institutional ownership, earnings, dividends, analyst recommendations and valuation. Profitability This table compares Q BioMed and Indaptus Therapeutics’ […]
Equities analysts expect that Indaptus Therapeutics, Inc. (NASDAQ:INDP – Get Rating) will post earnings per share of ($0.39) for the current quarter, Zacks Investment Research reports. Zero analysts have issued estimates for Indaptus Therapeutics’ earnings. Indaptus Therapeutics reported earnings of ($3.84) per share in the same quarter last year, which would indicate a positive year […]